Corcept Therapeutics
CORT
#2844
Rank
ยฃ4.41 B
Marketcap
ยฃ41.10
Share price
-2.22%
Change (1 day)
-26.61%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2026 (TTM): ยฃ4.32 Million

According to Corcept Therapeutics 's latest financial reports the company's current earnings are ยฃ0.76 Billion. In 2025 the company made an earning of ยฃ49.56 Million a decrease over its 2024 earnings that were of ยฃ0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) ยฃ4.32 M-91.27%
2025 ยฃ49.56 M-58.84%
2024 ยฃ0.12 B29.65%
2023 ยฃ92.88 M7.2%
2022 ยฃ86.64 M-7.05%
2021 ยฃ93.21 M-5.01%
2020 ยฃ98.13 M12.79%
2019 ยฃ87 M26.61%
2018 ยฃ68.71 M74.51%
2017 ยฃ39.37 M548.72%
2016 ยฃ6.06 M-227.03%
2015 -ยฃ4.78 Million-79.58%
2014 -ยฃ23.41 Million-31.79%
2013 -ยฃ34.31 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.37 B 358,527.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ11.76 B 217,790.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ7.89 B 146,103.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ23.20 B 429,565.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ9.80 B 181,457.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ7.15 B 132,382.05%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
ยฃ1.04 M-80.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-ยฃ20.47 Million-478.81%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.28 B 5,222.94%๐Ÿ‡บ๐Ÿ‡ธ USA